A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-α and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics

International Journal of Gynecological Pathology

Volumn 28, Issue 2, 2009, Pages 114-119

  Aximu, Dilinuer ^a   Azad, Azar ^a   Ni, Ruoyu ^a   Colgan, Terence ^a   Nanji, Shabin ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cervical adenocarcinoma in situ; Cervical invasive adenocarcinoma; Minichromosome maintenance protein 2; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) ALPHA; MINICHROMOSOME MAINTENANCE PROTEIN 2; PARAFFIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; BENIGN TUMOR; CERVICAL ADENOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; METAPLASIA; MICROGLANDULAR HYPERPLASIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE ENDOCERVIX;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; CELL CYCLE PROTEINS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; PILOT PROJECTS; REAGENT KITS, DIAGNOSTIC; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 68949221640     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181895573     Document Type: Article

References (31)

1. Mikuta J, Celebre J. Adenocarcinoma of the cervix. Obstet Gynecol 1969;33:753-756
2. Vesterinen E, Forss M, Niemenen U. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinomas including 112 tumors with glandular elements. Gynecol Oncol 1989;33:49-53. (Pubitemid 19106623)
3. Zaino RJ. Glandular lesions of the uterine cervix. Mod Pathol 2000;13:261-274
4. Zaino RJ. Symposium. Part I: Adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2002;21:314-326 (Pubitemid 35052697)
5. Marjoniemi VM. Immunohistochemistry in gynaecological pathology: a review. Pathology 2004;36:109-119
6. INK4a expression patterns points to high risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003;201:535-543
7. Kastan M, Barte J. Cell cycle checkpoints and cancer. Nature 2004;432:316-323
8. INK4a/ProEx C in cervical squamous intraepithelial lesions. Hum Pathol 2007;38:1335-1344
9. Shroyer K, Homer P, Heinz D, et al. Validation of a novel immunocytochemical assay for topoisomerase II-α and minichromosome maintenance protein 2 expression in cervical cytology. Cancer Cytopathol 2006;108:324-330 (Pubitemid 44583712)
10. TM C). Cancer Cytopathol 2006;108:494-500.
11. Badr R, Walts A, Chung F, et al. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol 2008;32:899-906.
12. Allred C, Harvey J, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155-168 (Pubitemid 28144151)
13. Mann H, Whitney D. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947;18:50-60.
14. Conover W. Practical Nonparametric Statistics. 3rd ed. New York: John Wiley; 1998:213-228
15. Marques T, Andrade L, Vassallo J. Endocervical tubal metaplasia and adenocarcinoma in situ: role of immunohistochemistry for carcinoembryonic antigen and vimentin in differential diagnosis. Histopathology 1996;28:549-550 (Pubitemid 126445333)
16. Cameron R, Maxwell P, Jenkins D, et al. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tuboendometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002;41:313-321 (Pubitemid 35279028)
17. Pirog E, Isacson C, Szabolcs M, et al. Proliferative activity of benign and neoplastic endocervical epithelium and correlation with HPV DNA detection. Int J Gynecol Pathol 2002;21:22-26 (Pubitemid 34008349)
18. INK4A, and early endocervical glandular neoplasia. Hum Pathol 2002;33:899-904.
19. Negri G, Egarter-Vigl E, Kasal A, et al. p16INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. An immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003;27:187-193 (Pubitemid 36152227)
20. Pavlakis K, Messini I, Athanassiadou S, et al. Endocervical glandular lesions: a diagnostic approach combining a semiquantitative scoring method to the expression of CEA, MIB-1 and p16. Gynecol Oncol 2006;103:971-976 (Pubitemid 44821324)
21. Van Hoeven K, Ramondetta L, Kovatich A, et al. Quantitative image analyst of MIB1 reactivity in inflammatory, hyperplastic and neoplastic endocervical lesions. Int J Gynecol Pathol 1997;16:15-21. (Pubitemid 27199580)
22. Cina S, Richardson M, Austin R, et al. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10:176-180 (Pubitemid 27130454)
23. McCluggage W, McBride H, Maxwell P, et al. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions. Int J Gynecol Pathol 1997;16:22-27 (Pubitemid 27199581)
24. McCluggage W, Maxwell P, McBride H, et al. Monoclonal antibodies Ki-67 and MIB-1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin fixed material. Int J Gynecol Pathol 1995;14:209-216
25. Lee K, Sun D, Crum C. Endocervical intraepithelial glandular atypia (dysplasia): a histopathologic, human papillomavirus and MIB-1 analysis of 25 cases. Hum Pathol 2000;31:656-664 (Pubitemid 30445467)
26. McCluggage W, Maxwell P. bcl-2 and p21 immunostaining of cervical tubo-endometrial metaplasia. Histopathology 2002;40:107-108 (Pubitemid 34107391)
27. Kruse A, Baak J, Helliesen T, et al. Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1501-1507 (Pubitemid 35239427)
28. Klaes R, Benner A, Friedrich T, et al. p16INK4A immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-1399 (Pubitemid 35239415)
29. INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2008;32:502-512
30. INK4a in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix. Arch Pathol Lab Med 2008;132:795-799
31. Pirog E, Baergen R, Soslow R, et al. Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol 2002;26:70-75 (Pubitemid 34019994)